• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用单层培养从人多能干细胞分化心肌细胞

Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture.

作者信息

Batalov Ivan, Feinberg Adam W

机构信息

Department of Materials Science & Engineering, Carnegie Mellon University, Pittsburgh, PA, USA.

Department of Materials Science & Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. ; Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA.

出版信息

Biomark Insights. 2015 May 27;10(Suppl 1):71-6. doi: 10.4137/BMI.S20050. eCollection 2015.

DOI:10.4137/BMI.S20050
PMID:26052225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4447149/
Abstract

Human pluripotent stem cells (PSCs) are a promising cell source for cardiac tissue engineering and cell-based therapies for heart repair because they can be expanded in vitro and differentiated into most cardiovascular cell types, including cardiomyocytes. During embryonic heart development, this differentiation occurs under the influence of internal and external stimuli that guide cells to go down the cardiac lineage. In order to differentiate PSCs in vitro, these or similar stimuli need to be provided in a controlled manner. However, because it is not possible to completely recapitulate the embryonic environment, the factors essential for cardiac differentiation of PSCs in vitro need to be experimentally determined and validated. Since PSCs were first developed, significant progress has been made in optimizing techniques for their differentiation toward cardiomyocytes. In this review, we will summarize recent advances in these techniques, with particular focus on monolayer-based methods that have improved the efficiency and scalability of cardiomyocyte differentiation.

摘要

人类多能干细胞(PSCs)是心脏组织工程和基于细胞的心脏修复治疗中一种很有前景的细胞来源,因为它们可以在体外扩增并分化为大多数心血管细胞类型,包括心肌细胞。在胚胎心脏发育过程中,这种分化是在内部和外部刺激的影响下发生的,这些刺激引导细胞走向心脏谱系。为了在体外分化PSCs,需要以可控的方式提供这些或类似的刺激。然而,由于不可能完全重现胚胎环境,因此需要通过实验确定和验证PSCs体外心脏分化所必需的因素。自从首次开发出PSCs以来,在优化其向心肌细胞分化的技术方面已经取得了重大进展。在这篇综述中,我们将总结这些技术的最新进展,特别关注基于单层培养的方法,这些方法提高了心肌细胞分化的效率和可扩展性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ca/4447149/b69b5bd9e1ab/bmi-suppl.1-2015-071f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ca/4447149/b69b5bd9e1ab/bmi-suppl.1-2015-071f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ca/4447149/b69b5bd9e1ab/bmi-suppl.1-2015-071f1.jpg

相似文献

1
Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture.利用单层培养从人多能干细胞分化心肌细胞
Biomark Insights. 2015 May 27;10(Suppl 1):71-6. doi: 10.4137/BMI.S20050. eCollection 2015.
2
Making cardiomyocytes: how mechanical stimulation can influence differentiation of pluripotent stem cells.制造心肌细胞:机械刺激如何影响多能干细胞的分化
Biotechnol Prog. 2013 Sep-Oct;29(5):1089-96. doi: 10.1002/btpr.1794. Epub 2013 Sep 12.
3
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.人类多能干细胞:作为用于体外建模和基于细胞的心脏修复的心肌细胞来源的前景与挑战。
Adv Drug Deliv Rev. 2016 Jan 15;96:3-17. doi: 10.1016/j.addr.2015.05.004. Epub 2015 May 14.
4
Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.在特定条件下人多能干细胞向心肌细胞的分化
Methods Mol Biol. 2016;1353:163-80. doi: 10.1007/7651_2014_178.
5
Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.从心脏中汲取的经验:在心脏发育过程中模拟电生理特征,以体外分化干细胞来源的心肌细胞。
J Mol Cell Cardiol. 2014 Feb;67:12-25. doi: 10.1016/j.yjmcc.2013.12.011. Epub 2013 Dec 23.
6
A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.一个用于从多能干细胞大规模生产人类心肌细胞的通用且强大的集成平台。
Stem Cells Transl Med. 2015 Dec;4(12):1482-94. doi: 10.5966/sctm.2014-0275. Epub 2015 Oct 28.
7
Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.从多能干细胞生成人类心肌细胞:最新进展。
Life Sci. 2016 Jan 15;145:98-113. doi: 10.1016/j.lfs.2015.12.023. Epub 2015 Dec 10.
8
Cell transplantation--a potential therapy for cardiac repair in the future?细胞移植——未来心脏修复的潜在疗法?
Heart Surg Forum. 2002;5(4):E28-34.
9
Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes.从人牙间充质干细胞高效生成无转基因和无饲养层的诱导多能干细胞及其向心肌细胞的化学限定分化。
Biochem Biophys Res Commun. 2018 Jan 22;495(4):2490-2497. doi: 10.1016/j.bbrc.2017.12.007. Epub 2017 Dec 5.
10
Manipulation of Pluripotent Stem Cell Metabolism for Clinical Application.用于临床应用的多能干细胞代谢调控
Curr Stem Cell Rep. 2017;3(1):28-34. doi: 10.1007/s40778-017-0073-9. Epub 2017 Feb 13.

引用本文的文献

1
Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review.用于疾病建模和胰岛素抵抗治疗中胰岛素靶细胞再生的人诱导多能干细胞(iPSC):综述
Cells. 2025 Aug 1;14(15):1188. doi: 10.3390/cells14151188.
2
Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases.基于诱导多能干细胞的再生疗法治疗人类衰老相关功能衰退和疾病
Cells. 2025 Apr 21;14(8):619. doi: 10.3390/cells14080619.
3
Modeling immune checkpoint inhibitor associated myocarditis and its therapeutic implications.

本文引用的文献

1
Doxycycline enhances survival and self-renewal of human pluripotent stem cells.强力霉素可提高人类多能干细胞的存活率和自我更新能力。
Stem Cell Reports. 2014 Aug 12;3(2):353-64. doi: 10.1016/j.stemcr.2014.06.013. Epub 2014 Jul 24.
2
Microfluidic organs-on-chips.微流控器官芯片。
Nat Biotechnol. 2014 Aug;32(8):760-72. doi: 10.1038/nbt.2989.
3
Human pluripotent stem cells on artificial microenvironments: a high content perspective.人工微环境中的人类多能干细胞:高内涵视角
免疫检查点抑制剂相关心肌炎的建模及其治疗意义。
J Mol Cell Cardiol Plus. 2024 Dec;10. doi: 10.1016/j.jmccpl.2024.100122. Epub 2024 Nov 20.
4
Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration.人诱导多能干细胞衍生心肌细胞在药物筛选和组织再生方面的最新进展。
Microphysiol Syst. 2020 Sep;4:2. doi: 10.21037/mps-20-3. Epub 2020 Sep 15.
5
Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model.窦房样心肌细胞分化作为一种生物起搏器模型。
Int J Mol Sci. 2024 Aug 23;25(17):9155. doi: 10.3390/ijms25179155.
6
Toward the latest advancements in cardiac regeneration using induced pluripotent stem cells (iPSCs) technology: approaches and challenges.利用诱导多能干细胞(iPSCs)技术实现心脏再生的最新进展:方法与挑战。
J Transl Med. 2024 Aug 22;22(1):783. doi: 10.1186/s12967-024-05499-8.
7
Targeting the I Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants.靶向 I 通道 PKA 磷酸化轴以恢复其在高风险 LQT1 变异体中的功能。
Circ Res. 2024 Sep 13;135(7):722-738. doi: 10.1161/CIRCRESAHA.124.325009. Epub 2024 Aug 21.
8
Healing the Ischaemic Heart: A Critical Review of Stem Cell Therapies.治疗缺血性心脏病:干细胞疗法的批判性综述
Rev Cardiovasc Med. 2023 Apr 19;24(4):122. doi: 10.31083/j.rcm2404122. eCollection 2023 Apr.
9
Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer.癌症治疗中的心血管毒性:在抗癌的同时保护心脏。
Curr Cardiol Rep. 2024 Sep;26(9):953-971. doi: 10.1007/s11886-024-02099-2. Epub 2024 Jul 23.
10
scaRNA20 promotes pseudouridylatory modification of small nuclear snRNA U12 and improves cardiomyogenesis.scaRNA20促进小核snRNA U12的假尿苷酸化修饰并改善心肌生成。
Exp Cell Res. 2024 Mar 1;436(1):113961. doi: 10.1016/j.yexcr.2024.113961. Epub 2024 Feb 9.
Front Pharmacol. 2014 Jul 2;5:150. doi: 10.3389/fphar.2014.00150. eCollection 2014.
4
Chemically defined generation of human cardiomyocytes.化学定义的人类心肌细胞生成。
Nat Methods. 2014 Aug;11(8):855-60. doi: 10.1038/nmeth.2999. Epub 2014 Jun 15.
5
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.利用诱导多能干细胞和心脏芯片技术构建巴特综合征的线粒体心肌病模型。
Nat Med. 2014 Jun;20(6):616-23. doi: 10.1038/nm.3545. Epub 2014 May 11.
6
Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells.三碘甲状腺原氨酸促进源自诱导多能干细胞的人心肌细胞成熟。
J Mol Cell Cardiol. 2014 Jul;72:296-304. doi: 10.1016/j.yjmcc.2014.04.005. Epub 2014 Apr 13.
7
Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study.21 个世界地区 1980 至 2010 年缺血性心脏病死亡率的时间趋势:2010 年全球疾病负担研究。
Circulation. 2014 Apr 8;129(14):1483-92. doi: 10.1161/CIRCULATIONAHA.113.004042. Epub 2014 Feb 26.
8
The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes.循环拉伸对人胚胎干细胞来源的心肌细胞成熟和 3D 组织形成的影响。
Biomaterials. 2014 Mar;35(9):2798-808. doi: 10.1016/j.biomaterials.2013.12.052. Epub 2014 Jan 11.
9
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.《2014年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
10
Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytes.胚胎干细胞来源与新生儿心肌细胞构建的心肌组织的功能差异。
Stem Cell Reports. 2013 Nov 7;1(5):387-96. doi: 10.1016/j.stemcr.2013.10.004. eCollection 2013.